Novel Biomarkers for Clinical Diagnosis and Prognosis
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Clinical Diagnosis and Prognosis".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 11
Special Issue Editor
Interests: hemato-oncololgy; biomarkers; personalized medicine; molecular signatures; prognosis; predictive diagnosis; blood analysis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Biomarkers are essential in diagnosing a disease or pathogenic process, monitoring patients, and providing a prognosis for patients. Any biological indicator that can be tested can be utilized as a biomarker, including DNA, RNA, proteins, metabolites, blood, urine, and so on. Other physiological and morphological biomarkers may also be measured or used for clinical or diagnostic imaging.
Biomarkers are of significant therapeutic value in early disease diagnosis, before clinical symptoms have fully manifested; they have the potential to prolong the lives of patients or enhance their quality of life.
This Special Issue investigates the advancing field of novel biomarkers in clinical diagnosis and prognosis, as well as their applications, which offer innovative approaches to patient care.
Dr. Ji Hyun Park
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomarkers
- personalized medicine
- molecular signatures
- prognosis predictive diagnostics
- prognostic diagnostics
- genetic biomarkers
- blood analysis
- liquid biopsy
- tumor marker
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
